Why the study?
Vasoplegic syndrome commonly follows cardiothoracic surgery, but research into its treatment is limited and mostly extrapolated from septic shock.
Design
Review
Authors
Loading...
Treatment of post-cardiac surgery vasoplegia warrants caution given limited evidence; leaves open dedicated trials of novel catecholamine-sparing options.
This review highlights the complex pathophysiology of vasoplegic syndrome post-cardiothoracic surgery and the evolving, albeit limited, treatment options including catecholamine-sparing agents.
Busse et al. (2020) studied this question.